BME:PHMBiotechs
A Look At Pharma Mar (BME:PHM) Valuation As Dividend Proposal Puts Shareholder Returns In Focus
Pharma Mar (BME:PHM) has proposed a dividend of €1.00 per share. This corporate action directly affects potential cash returns for shareholders and helps frame how you might view the stock today.
See our latest analysis for Pharma Mar.
The proposed €1.00 dividend comes alongside solid momentum in the share price, with a 7 day share price return of 5.62%, a 90 day share price return of 26.72%, and a 3 year total shareholder return of 212.27%. This suggests investors have been rewarding the...